nach oben

American Journal of Clinical Dermatology

Erschienen in:

01.10.2014 | Review Article

Neutrophilic Dermatoses: An Update

verfasst von: Afsaneh Alavi, Dusan Sajic, Felipe B. Cerci, Danny Ghazarian, Misha Rosenbach, Joseph Jorizzo

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Neutrophilic dermatoses constitute a heterogeneous group of dermatologic diseases, which are unified by the predominance of neutrophils within the inflammatory infiltrate on histopathology. The aims of this review were to provide an update on the clinical and histologic presentation of the main neutrophilic dermatoses and to develop a guide for clinical practice. A structured literature search of PubMed, Medline, and Embase was performed, using the key words “neutrophilic disorders”, “cutaneous small vessel vasculitis”, “Sweet’s syndrome”, “bowel associated dermatosis arthritis syndrome”, “Behcet’s”, “palisaded neutrophilic and granulomatous dermatosis”, “rheumatoid neutrophilic dermatitis”, and “pyoderma gangrenosum”. Related articles were screened for key terms and were included if appropriate. This group contains a wide spectrum of unique disorders, each with its own histologic and clinical subtleties, making specific diagnosis of a given entity within the group diagnostically challenging. The fact that overlapping forms of neutrophilic dermatoses, which share features of multiple neutrophilic dermatoses, are not uncommon makes the diagnoses more challenging.

Jorizzo JL, Solomon AR, Zanolli MD, Leshin B. Neutrophilic vascular reactions. J Am Acad Dermatol. 1988;19(6):983–1005.PubMedCrossRef

Berk DR, Bayliss SJ. Neutrophilic dermatoses in children. Pediatr Dermatol. 2008;25(5):509–19.PubMedCrossRef

Kinney MA, Jorizzo JL. Small-vessel vasculitis. Dermatol Ther. 2012;25(2):148–57.PubMedCrossRef

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.PubMedCrossRef

Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: approach to diagnosis and treatment. Int J Dermatol. 2006;45(1):3–13.PubMedCrossRef

Sais G, Vidaller A, Jucgla A, Servitje O, Condom E, Peyri J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol. 1998;134(3):309–15.PubMedCrossRef

Ekenstam E, Callen JP. Cutaneous leukocytoclastic vasculitis: clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol. 1984;120(4):484–9.CrossRef

Caucanas M, Heylen A, Rolland F, Muller G, Olemans C, Sass U, et al. Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet’s syndrome: the concept of neutrophilic disease. Int J Dermatol. 2013;52(10):1185–8.PubMed

Swerlick RA, Lawley TJ. Cutaneous vasculitis: its relationship to systemic disease. Med Clin N Am. 1989;73(5):1221–35.PubMed

10.

Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27(6):504–28.PubMedCrossRef

11.

Peuvrel L, Quereux G, Brocard A, Saint-Jean M, Freour E, Josselin N, et al. Atypical cutaneous vasculitis under lapatinib. Eur J Dermatol. 2013;23(4):540–1.PubMed

12.

Novoa RA, Honda K, Koon HB, Gerstenblith MR. Vasculitis and panniculitis associated with vemurafenib. J Am Acad Dermatol. 2012;67(6):e271–2.PubMedCrossRef

13.

Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Cutaneous small-vessel vasculitis associated with solid organ malignancies: the Mayo Clinic experience, 1996–2009. J Am Acad Dermatol. 2012;66(2):e55–65.PubMedCrossRef

14.

Ingraffea A, Donohue K, Wilkel C, Falanga V. Cutaneous vasculitis in two patients taking an herbal supplement containing black cohosh. J Am Acad Dermatol. 2007;56(5 Suppl):S124–6.PubMedCrossRef

15.

Podjasek JO, Wetter DA, Pittelkow MR, Wada DA. Henoch-Schonlein purpura associated with solid-organ malignancies: three case reports and a literature review. Acta Derm Venereol. 2012;92(4):388–92.PubMedCrossRef

16.

Lever WF, Schaumburg-Lever S. Histopathology of the skin. Philadelphia: JB Lippincott; 1990.

17.

Zax RH, Hodge SJ, Callen JP. Cutaneous leukocytoclastic vasculitis: serial histopathologic evaluation demonstrates the dynamic nature of the infiltrate. Arch Dermatol. 1990;126(1):69–72.PubMedCrossRef

18.

Bahrami S, Malone JC, Webb KG, Callen JP. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol. 2006;142(2):155–61.PubMedCrossRef

19.

Haeberle MT, Adams WB, Callen JP. Treatment of severe cutaneous small-vessel vasculitis with mycophenolate mofetil. Arch Dermatol. 2012;148(8):887–8.PubMedCrossRef

20.

Sokumbi O, Wetter DA, Makol A, Warrington KJ. Vasculitis associated with tumor necrosis factor-alpha inhibitors. Mayo Clin Proc. 2012;87(8):739–45.PubMedCrossRefPubMedCentral

21.

Rochet NM, Chavan RN, Cappel MA, Wada DA, Gibson LE. Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol. 2013;69(4):557–64.PubMedCrossRef

22.

Anzalone CL, Cohen PR. Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Curr Opin Hematol. 2013;20(1):26–35.PubMedCrossRef

23.

Paydas S. Sweet’s syndrome: a revisit for hematologists and oncologists. Crit Rev Oncol/Hematol. 2013;86(1):85–95.CrossRef

24.

Cohen PR. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol. 2009;10(5):301–12.PubMedCrossRef

25.

Marzano AV, Ishak RS, Saibeni S, Crosti C, Meroni PL, Cugno M. Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol. 2013;45(2):202–10.PubMedCrossRef

26.

Walker DC, Cohen PR. Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol. 1996;34(5 Pt 2):918–23.PubMedCrossRef

27.

Bonamigo RR, Razera F, Olm GS. Neutrophilic dermatoses: part I. An Bras Dermatol. 2011;86(1):11–25 (quiz 26–7).PubMedCrossRef

28.

Parsapour K, Reep MD, Gohar K, Shah V, Church A, Shwayder TA. Familial Sweet’s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol. 2003;49(1):132–8.PubMedCrossRef

29.

Razera F, Olm GS, Bonamigo RR. Neutrophilic dermatoses: part II. An Bras Dermatol. 2011;86(2):195–209 (quiz 210–1).PubMedCrossRef

30.

Vanourny J, Swick BL. Sweet syndrome with systemic inflammatory response syndrome. Arch Dermatol. 2012;148:969–70.

31.

Heymann WR. Histiocytoid Sweet syndrome. J Am Acad Dermatol. 2009;61(4):693–4.PubMedCrossRef

32.

Requena L, Kutzner H, Palmedo G, Pascual M, Fernandez-Herrera J, Fraga J, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141(7):834–42.PubMedCrossRef

33.

Chavan RN, Cappel MA, Ketterling RP, Wada DA, Rochet NM, Knudson R, et al. Histiocytoid Sweet syndrome may indicate leukemia cutis: a novel application of fluorescence in situ hybridization. J Am Acad Dermatol. 2014;70(6):1021–7.PubMedCrossRef

34.

Raza S, Kirkland RS, Patel AA, Shortridge JR, Freter C. Insight into Sweet’s syndrome and associated-malignancy: a review of the current literature. Int J Oncol. 2013;42(5):1516–22.

35.

Halawai A, Abiad F, Abbas O. Bariatric surgery and its effects on the skin and skin diseases. Obes Surg. 2013;23:408–13.

36.

Dicken CH, Seehafer JR. Bowel bypass syndrome. Arch Dermatol. 1979;115:837–9.

37.

Tu J, Chan JJ, Yu LL. Bowel bypass syndrome/bowel-associated dermatosis arthritis syndrome post laparoscopic gastric bypass surgery. Aust J Dermatol. 2011;52:e5–7.

38.

Jorizzo JL, Apisarnthanarax P, Subrt P, Hebert AA, Henry JC, Raimer SS, et al. Bowel-bypass syndrome without bowel bypass. Bowel-associated dermatosis-arthritis syndrome. Arch Int Med. 1983;143:457–61.

39.

Slater GH, Kerlin P, Georghiou PR, Fielding GA. Bowel-associated dermatosis-arthritis syndrome after biliopancreatic diversion. Obes Surg. 2004;14:133–5.

40.

Prpic-Massari L, Kastelan M, Brajac I, Cabrijan L, Zamolo G, Massari D. Bowel-associated dermatosis–arthritis syndrome in a patient with appendicitis. Med Sci Monit. 2007;13(8):CS97–100.PubMed

41.

Mendoza-Pinto C, Garcia-Carrasco M, Jimenez-Hernandez M, Jimenez Hernandez C, Riebeling-Navarro C, Nava Zavala A, et al. Etiopathogenesis of Behcet’s disease. Autoimmun Rev. 2010;9:241–5.

42.

Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease: from East to West. Clin Rheumatol. 2010;29:823–33.

43.

Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M, et al. Behcet’s disease in Iran: analysis of 6500 cases. Int J Rheum Dis. 2010;13(4):367–73.PubMedCrossRef

44.

Hatemi G, Seyahi E, Fresko I, Hamuryudan V. Behcet’s syndrome: a critical digest of the recent literature. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S80–9.

45.

Zhou ZY, Chen SL, Shen N, Lu Y. Cytokines and Behcet’s disease. Autoimmun Rev. 2012;11:699–704.

46.

Emmi G, Silvestri E, Ciucciarelli L, Squatrito D, Emmi L. Anti-IL1 blocking agents in drug-resistant Behcet’s syndrome: our little case series. Clin Exp Rheum. Epub 2014 Apr 7.

47.

Urbaniak P, Hasler P, Kretzschmar S. Refractory neuro-Behcet treated by tocilizumab: a case report. Clin Exp Rheumatol. 2012;30(3 Suppl 72):S73–5.PubMed

48.

Ozen S, Eroglu FK. Pediatric-onset Behcet disease. Curr Opin Rheumatol. 2013;25(5):636–42.PubMedCrossRef

49.

Wilmoth GJ, Perniciaro C. Cutaneous extravascular necrotizing granuloma (Winkelmann granuloma): confirmation of the association with systemic disease. J Am Acad Dermatol. 1996;34(5 Pt 1):753–9.PubMedCrossRef

50.

Kim SK, Park CK, Park YW, Jun JB, Yoo DH, Bae SC. Palisaded neutrophilic granulomatous dermatitis presenting as an unusual skin manifestation in a patient with Behcet’s disease. Scand J Rheumatol. 2005;34(4):324–7.PubMedCrossRef

51.

Hantash BM, Chiang D, Kohler S, Fiorentino D. Palisaded neutrophilic and granulomatous dermatitis associated with limited systemic sclerosis. J Am Acad Dermatol. 2008;58(4):661–4.PubMedCrossRef

52.

Kreuter A, Rose C, Zillikens D, Altmeyer P. Bullous rheumatoid neutrophilic dermatosis. J Am Acad Dermatol. 2005;52(5):916–8.PubMedCrossRef

53.

Fujio Y, Funakoshi T, Nakayama K, Amagai M, Ohyama M. Rheumatoid neutrophilic dermatosis with tense blister formation: a case report and review of the literature. Australas J Dermatol. 2012;.;55((1):):e12–4.

54.

Sangueza OP, Caudell MD, Mengesha YM, Davis LS, Barnes CJ, Griffin JE, et al. Palisaded neutrophilic granulomatous dermatitis in rheumatoid arthritis. J Am Acad Dermatol. 2002;47(2):251–7.PubMedCrossRef

55.

Biswas A, Chittari K, van Gey Pittius D, Stephens M, Tan BB. Palisaded neutrophilic and granulomatous dermatitis in a child with type I diabetes mellitus and coeliac disease. Br J Dermatol. 2008;159(2):488–9.PubMedCrossRef

56.

Germanas JP, Mehrabi D, Carder KR. Palisaded neutrophilic granulomatous dermatitis in a 12-year-old girl with systemic lupus erythematosus. J Am Acad Dermatol. 2006;55(2 Suppl):S60–2.PubMedCrossRef

57.

Hunt RD, Hartman RD, Molho-Pessach V, Votava HJ, Schaffer JV. Palisaded neutrophilic and granulomatous dermatitis in an adolescent girl with perinuclear antineutrophil cytoplasmic antibody-positive pauci-immune glomerulonephritis and arthritis. J Am Acad Dermatol. 2012;67(4):e164–6.PubMedCrossRef

58.

Chu P, Connolly MK, LeBoit PE. The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol. 1994;130(10):1278–83.PubMedCrossRef

59.

Ergun T, Inanc N, Tuney D, Kotiloglu EK, Seckin D, Tetik C, et al. Skin manifestations of rheumatoid arthritis: a study of 215 Turkish patients. Int J Dermatol. 2008;47(9):894–902.PubMedCrossRef

60.

Bremner R, Simpson E, White CR, Morrison L, Deodhar A. Palisaded neutrophilic and granulomatous dermatitis: an unusual cutaneous manifestation of immune-mediated disorders. Semin Arthritis Rheum. 2004;34(3):610–6.PubMedCrossRef

61.

Edgerton CC, Oglesby RJ, Bray D. Rheumatoid neutrophilic dermatitis. J Clin Rheum. 2006;12(5):266–7.CrossRef

62.

Yamamoto T, Ohkubo H, Nishioka K. Skin manifestations associated with rheumatoid arthritis. J Dermatol. 1995;22(5):324–9.PubMed

63.

Bevin AA, Steger J, Mannino S. Rheumatoid neutrophilic dermatitis. Cutis. 2006;78(2):133–6.PubMed

64.

Sanchez JL, Cruz A. Rheumatoid neutrophilic dermatitis. J Am Acad Dermatol. 1990;22(5 Pt 2):922–5.PubMedCrossRef

65.

Hirota TK, Keough GC, David-Bajar K, McCollough ML. Rheumatoid neutrophilic dermatitis. Cutis. 1997;60(4):203–5.PubMed

66.

Setterfield JF, Shirlaw PJ, Challacombe SJ, Black MM. Pyoderma gangrenosum associated with severe oropharyngeal involvement and IgA paraproteinaemia. Br J Dermatol. 2001;144(2):393–6.PubMedCrossRef

67.

Ahronowitz I, Harp J, Shinkai K. Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol. 2012;13(3):191–211.PubMedCrossRef

68.

Perry HO, Winkelmann RK. Bullous pyoderma gangrenosum and leukemia. Arch Dermatol. 1972;106(6):901–5.PubMedCrossRef

69.

O’Loughlin S, Perry HO. A diffuse pustular eruption associated with ulcerative colitis. Arch Dermatol. 1978;114(7):1061–4.PubMedCrossRef

70.

Su WP, Davis MD, Weenig RH, Powell FC, Perry HO. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol. 2004;43(11):790–800.PubMedCrossRef

71.

Brooklyn TN, Dunnill MG, Shetty A, Bowden JJ, Williams JD, Griffiths CE, et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut. 2006;55(4):505–9.PubMedCrossRefPubMedCentral

72.

Dinarello CA. A clinical perspective of IL-1beta as the gatekeeper of inflammation. Eur J Immunol. 2011;41(5):1203–17.PubMedCrossRef

73.

Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol. 2011;64(5):950–4.PubMedCrossRef

74.

Weenig RH, Davis MD, Dahl PR, Su WP. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med. 2002;347(18):1412–8.PubMedCrossRef

Titel: Neutrophilic Dermatoses: An Update
verfasst von: Afsaneh Alavi
Dusan Sajic
Felipe B. Cerci
Danny Ghazarian
Misha Rosenbach
Joseph Jorizzo
Publikationsdatum: 01.10.2014
Verlag: Springer International Publishing
Erschienen in: American Journal of Clinical Dermatology / Ausgabe 5/2014
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI: https://doi.org/10.1007/s40257-014-0092-6

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Dermatologie

22.04.2024 | DGIM 2024 | Nachrichten

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Neutrophilic Dermatoses: An Update

Abstract

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2014

Imiquimod in the Treatment of Cutaneous Warts: An Evidence-Based Review

Dermatological Toxicity Associated with Targeted Therapies in Cancer: Optimal Management

Interferon-Based Treatment for Patients with Mycosis Fungoides and Hepatitis C Virus Infection: A Case Series

Treatment of Pediculosis Capitis: A Critical Appraisal of the Current Literature

Neonatal Junctional Epidermolysis Bullosa: Treatment Conundrums and Ethical Decision Making

Biologic Therapy with or Without Topical Treatment in Psoriasis: What Does the Current Evidence Say?

Leitlinien kompakt für die Dermatologie

Neu im Fachgebiet Dermatologie

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Kein Abstrich bei chronischen Wunden ohne Entzündungszeichen!

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

Vitiligo: Prävalenz steigt und viele Erkrankte werden spät behandelt

Update Dermatologie